Why I’ve Bought Royal Bank of Scotland Group plc

Turnaround play Royal Bank of Scotland Group plc (LON:RBS) is finally turning.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RBSSo you’re a contrarian investor? Well, what is the most obvious contrarian investment since the Financial Crisis? Well, the banks, of course.

And which is the most contrarian of the banks? Well, Royal Bank of Scotland (LSE: RBS) (NYSE: RBS.US), of course. With a mountain of debt, and caught in the vortex of the Credit Crunch, this was the ultimate contrarian play.

And this showed in the share price, which fell to an astonishing 1/50th of its pre-Crisis high. So, when you think the share price has bottomed, you come along and buy in. Sure thing, huh? And so ensues…. well, a lot of pain.

With hindsight, it is not surprising that RBS would not recover quickly. Having suffered such horrendous losses, the only way this bank would ever recover was very slowly and very painstakingly.

Most investors had thrown in the towel

It’s seven years since the Financial Crisis struck, and this bank’s share price has still not broken out of its range. No matter how patient an investor you are, by this point you will have thrown in the towel. Many an investor would have given up, sold their shares, and concluded that the share price would never recover.

This is penultimate thinking: you see what has been happening recently, and assume that it will always be like this.

But wait a moment — let’s dig a little deeper. Look at the latest results. Pre-tax profits for the first six months of the year have doubled from £1.374bn to £2.652bn. Losses from impairments have tumbled from £1.881bn to £269m. The selling off of assets is progressing well. Even the heavily-loss making Ulster Bank is now turning a profit.

Signs of real progress

What’s more, a key measure of the bank’s financial strength, its core tier 1 capital ratio, has improved dramatically, increasing from 8.6% to 10.1%. And the cost:income ratio is also improving.

The fact is that, ever since the Crisis hit, RBS has been working hard to recover. After years of hard graft, the fruits of this work are only now showing through, and it looks like the company is finally turning around.

So is it all roses from now on? Of course not. There will still be volatility; there will, as Chief Executive Ross McEwan has said, still be bumps in the road. The bank’s rebuilding process is continuing.

But, for the first time, I see signs here of real progress. And I have been convinced enough to buy shares in this business. After all, you don’t buy into a company once it has fully recovered, but when the turnaround is just beginning. And this is why I’ve bought RBS.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Prabhat Sakya owns shares in RBS. The Motley Fool has no position in any of the shares mentioned.

More on Investing Articles

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

With £1,000 to invest, should I buy growth stocks or income shares?

Dividend shares are a great source of passive income, but how close to retirement, should investors think about shifting away…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

Warren Buffett should buy this flagging FTSE 100 firm!

After giving $50bn to charity, Warren Buffett still has a $132bn fortune. Also, his company has $168bn to spend, so…

Read more »

Middle-aged white man wearing glasses, staring into space over the top of his laptop in a coffee shop
Investing For Beginners

I wish I’d known about this lucrative style of stock market investing 20 years ago

Research has shown that over the long term, this style of investing can generate returns in excess of those provided…

Read more »

Woman using laptop and working from home
Investing Articles

Is this growing UK fintech one of the best shares to buy now?

With revenues growing at 24% and income growing at 36%, Wise looks like one of the best shares to buy…

Read more »

Dividend Shares

Are Aviva shares one of the UK’s best investments today?

UK investors have been piling into Aviva shares recently. However, Edward Sheldon's wondering if he could get bigger returns elsewhere.

Read more »

Older couple walking in park
Investing Articles

10.2% dividend yield! 2 value shares to consider for a £1,530 passive income

Royston Wild explains why investing in these value shares could provide investors with significant passive income for years to come.

Read more »

man in shirt using computer and smiling while working in the office
Investing Articles

Nvidia and a FTSE 100 fund own a 10% stake in this $8 artificial intelligence (AI) stock

Ben McPoland explores Recursion Pharmaceuticals (NASDAQ:RXRX), an up-and-coming AI firm held by Cathie Wood, Nvidia and one FTSE 100 trust.

Read more »

Electric cars charging in station
Investing Articles

Is NIO stock poised for a great rebound?

NIO stock has risen 24.5% over the past month, coming off its lows following a solid month of vehicle deliveries.…

Read more »